NDAORALTABLET, CHEWABLE
Approved
Jun 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IMODIUM MULTI-SYMPTOM RELIEF is a fixed-dose combination of loperamide hydrochloride (an antiperistaltic agent) and simethicone (an anti-flatulent) in chewable tablet form for oral use. It treats acute diarrhea and associated gastrointestinal symptoms including gas, bloating, and discomfort. The combination addresses multiple GI symptoms with a single dose, targeting symptomatic relief in over-the-counter and pharmacy-supervised settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating defensive commercial strategy and possible team consolidation or pivot to adjacent OTC franchises.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on IMODIUM MULTI-SYMPTOM RELIEF offers experience in mature, high-volume OTC portfolio management, pharmacy channel strategy, and defensive commercial execution. This role suits professionals seeking hands-on brand defense, consumer marketing, or retail pharmacy strategy before transitioning to growth-stage franchises or specialty care.
Brand ManagerCommercial Operations Manager
Worked on IMODIUM MULTI-SYMPTOM RELIEF at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.